Purpose To systematically review and meta-analyse published data on the diagnostic
performance of 18 F-FDG PET/CT in detecting bone marrow involvement in patients with …

Background This study aimed to systematically review and meta-analyze published data on
the diagnostic performance of 18 F-fluoro-2-deoxy-d-glucose positron emission …

Advances in the management of Hodgkin lymphoma in children, adolescents and young
adult have resulted in survival outcomes exceeding 90%. The risk of late toxicity, however …

Bone marrow involvement in lymphoma may have prognostic and therapeutic
consequences. Bone marrow biopsy (BMB) is the established method for the evaluation of …

Hematologic malignancies comprise a set of prevalent yet clinically diverse diseases that
can affect every organ system. Because blood components originate in bone marrow, it is no …

The ability of positron emission tomography‐computerized tomography (PET‐CT) to
accurately detect bone marrow involvement (BMI) has been suggested in Hodgkin …

Background Non-Hodgkin's lymphoma (NHL) accounts for around 4% of new cancer cases
annually. Bone marrow involvement is important for staging and management …

The biology and clinical impact of bone marrow (BM) infiltration in patients with diffuse large
B-cell lymphoma (DLBCL) remains unclear in the rituximab era. We retrospectively analyzed …

Purpose To determine the incidence of diffusely increased bone marrow 18F‐fluoro‐2‐
deoxy‐D‐glucose (FDG) uptake at positron emission tomography (PET) in recently …

Whether FDG PET/CT can replace bone marrow biopsy (BMBx) is undecided in patients with
diffuse large B cell lymphoma (DLBCL). We compared the visual PET findings and PET …